292 related articles for article (PubMed ID: 17628443)
21. Regulation of connective tissue synthesis in systemic sclerosis.
Varga J; Bashey RI
Int Rev Immunol; 1995; 12(2-4):187-99. PubMed ID: 7650421
[TBL] [Abstract][Full Text] [Related]
22. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
[TBL] [Abstract][Full Text] [Related]
23. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
25. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling.
Kanaoka M; Yamaguchi Y; Komitsu N; Feghali-Bostwick CA; Ogawa M; Arima K; Izuhara K; Aihara M
J Dermatol Sci; 2018 May; 90(2):199-208. PubMed ID: 29433908
[TBL] [Abstract][Full Text] [Related]
26. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A
J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469
[TBL] [Abstract][Full Text] [Related]
27. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
Shi-wen X; Kennedy L; Renzoni EA; Bou-Gharios G; du Bois RM; Black CM; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2007 Dec; 56(12):4189-94. PubMed ID: 18050250
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
29. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M
J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720
[TBL] [Abstract][Full Text] [Related]
30. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta.
Xu WD; Leroy EC; Smith EA
J Rheumatol; 1991 Feb; 18(2):241-6. PubMed ID: 2023218
[TBL] [Abstract][Full Text] [Related]
32. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
33. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
34. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
Trojanowska M
Curr Opin Rheumatol; 2009 Nov; 21(6):623-9. PubMed ID: 19713852
[TBL] [Abstract][Full Text] [Related]
35. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
36. SLC39A7 upregulation links to skin fibrosis in systemic sclerosis via TGF-β/SMAD pathway.
Wen X; Aoi J; Mijee T; Kajihara I; Makino K; Fukushima S
J Dermatol; 2024 Jun; 51(6):863-868. PubMed ID: 38217370
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
38. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
Shi-wen X; Pennington D; Holmes A; Leask A; Bradham D; Beauchamp JR; Fonseca C; du Bois RM; Martin GR; Black CM; Abraham DJ
Exp Cell Res; 2000 Aug; 259(1):213-24. PubMed ID: 10942593
[TBL] [Abstract][Full Text] [Related]
39. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
[TBL] [Abstract][Full Text] [Related]
40. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
